News

The 9th Healthcare+ EXPO Taiwan will take place from December 4–7 at Hall 1, Taipei Nangang Exhibition Center. This premier event spans the medical, ICT, technology, biopharmaceutical, and medical device sectors, connecting the full ecosystem of the health industry. As a one-stop Contract Development and Manufacturing Organization (CDMO), Amaran Biotech offers integrated solutions, including vaccine adjuvant AB-801 (QS-21), drug substance manufacturing, and aseptic drug product filling. This year, Amaran Biotech has been invited by the Hsinchu Science Park to participate in the “Science Park Pavilion” joint exhibition. Visit us at Booth N613a, and we warmly welcome industry partners for dialogue […]

Is the efficacy of your biologic product truly consistent? In biologics quality control—covering vaccines, antitoxins, monoclonal antibodies, and gene therapy products—the potency assay is a critical measure of biological activity. A well-designed and validated in vivo potency assay, complemented by a sensitive ELISA-based analytical system, forms the scientific foundation for demonstrating product efficacy, ensuring batch-to-batch consistency, and maintaining regulatory compliance. At Amaran Biotech, we understand the technical and biological challenges of developing robust mouse potency assays. Below are the three essential pillars for establishing a reliable potency evaluation framework—integrating ELISA analytics for quantitative precision and reproducibility. I. 🎯 Define the […]

Amaran Biotech, a leading Contract Development and Manufacturing Organization (CDMO) and advanced adjuvant provider, is continuing its commitment to quality excellence and operational efficiency through the implementation of a comprehensive electronic Quality Management System (eQMS), Simploud. This strategic move is designed to ensure the highest standards of product quality and patient safety, maintain rigorous regulatory compliance and audit readiness, enhance operational efficiency, reduce costs, and improve data integrity through paperless operation. Amaran Biotech is pleased to announce the successful rollout and go-live of the electronic Standard Operating Procedures (eSOP) module. This critical milestone signifies an important step in transitioning from […]

Amaran Biotech is pleased to announce our participation in the 7th Vaccine World Asia Congress 2025 – South East Asia, where we will introduce our proprietary AB-801(QS-21) vaccine adjuvant and share insights into how it accelerates vaccine commercialization. Presentation Details: Join us at this premier regional vaccine event to explore how Amaran Biotech addresses the QS-21 paradox and empowers partners with superior adjuvant technology for next-generation vaccine development. 🔗 Event Website: Vaccine World Asia Congress 2025 – South East Asia

Amaran Biotech will participate in BioJapan 2025 from October 8–10 at Pacifico Yokohama, together with BPIPO(Biotechnology and Pharmaceutical Industries Promotion Office), DCB(Development Center for Biotechnology), and fellow biotech companies from Taiwan. As one of Asia’s most influential biotech and pharma exhibitions, BioJapan brings together exhibitions, seminars, and partnering meetings, serving as a key platform for global collaboration. 📍 You can find us at the Taiwan Pavilion, Booth B-77.🤝 Book a meeting with us by searching “Amaran” on the BioJapan partnering platform, or contact us directly at service@amaranbiotech.com. We look forward to meeting our partners and exploring new opportunities in Yokohama.

In the pharmaceutical sector, the pathway from innovative science to successful commercialization is governed by two inseparable forces: Scientific Progress and Regulatory Integrity. At Amaran Biotech, our Quality Assurance philosophy is proactive and deeply integrated. We employ a Quality by Design (QbD) approach to establish our systems, building quality into our processes from the earliest stages. Our entire framework is meticulously structured to exceed global Good Manufacturing Practice (GMP) requirements, creating a robust and scalable process ready for large-scale production. Furthermore, our commitment extends to rigorous continuous improvement. Through robust data analysis and a disciplined Corrective and Preventive Action (CAPA) […]

Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was awarded the “Best Fill-Finish” at the 2025 Asia-Pacific Biologics CDMO Excellence Awards held in Singapore on September 10. This honor recognizes Amaran Biotech’s leading capabilities in aseptic fill-finish processes and marks an important step for Taiwan’s biotech industry on the international stage. The Asia-Pacific Biologics CDMO Excellence Awards, organized by the renowned international consulting firm IMAPAC, celebrate CDMOs in the region that have made outstanding contributions to biologics innovation and manufacturing. This year, Amaran Biotech was nominated for its achievements in supporting international clients with large-molecule drug fill-finish and […]